Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
about
The challenge of comorbidity in clinical trials for multiple sclerosisRecommendations for observational studies of comorbidity in multiple sclerosis.Importance of Apolipoprotein A-I in Multiple SclerosisMultiple Sclerosis and Obesity: Possible Roles of AdipokinesA lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosisThe role of epigenetic mechanisms and processes in autoimmune disordersAlpha-tocopherol and MRI outcomes in multiple sclerosis--association and predictionSimultaneous determination of oxysterols, cholesterol and 25-hydroxy-vitamin D3 in human plasma by LC-UV-MSCardiovascular Dysfunction in Multiple Sclerosis.Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors.The influence of nutritional factors on the prognosis of multiple sclerosis.Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureHumoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple SclerosisThe association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis.HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patients.Machine-Learned Data Structures of Lipid Marker Serum Concentrations in Multiple Sclerosis Patients Differ from Those in Healthy Subjects.Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARβ/δ: a potential therapeutic role for CNS autoimmune disease.Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.Multiple sclerosis in 2011: Advances in therapy, imaging and risk factors in MS.Female reproductive issues in multiple sclerosis.Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.Arterial, venous and other vascular risk factors in multiple sclerosis.An adverse lipid profile is associated with disability and progression in disability, in people with MS.HDL and cholesterol handling in the brain.Aging and multiple sclerosis.Multiple sclerosis: Presence of serum antibodies to lipids and predominance of cholesterol recognition.Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course.Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.Comorbidity in multiple sclerosis: implications for patient care.Central Nervous System Demyelination and Remyelination is Independent from Systemic Cholesterol Level in Theiler's Murine Encephalomyelitis.New candidates for CD4 T cell pathogenicity in experimental neuroinflammation and multiple sclerosis.Determining Causation from Observational Studies: A Challenge for Modern Neuroepidemiology.Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis.Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis.Discriminative ability of quality of life measures in multiple sclerosis.Low-Density Lipoprotein Receptor Deficiency Attenuates Neuroinflammation through the Induction of Apolipoprotein E.
P2860
Q26765031-C36C7FF7-B64C-491B-BCAD-3B7E72D87858Q26766688-285B20F0-9716-4F46-B1FD-474317AFFE58Q26774792-51C92367-0D53-4D0C-93D7-68BB947A44DBQ28078518-0FD235C7-E283-493B-A6E5-00D040F16D02Q28384280-759A59A4-8C38-4848-8574-441FD0088CFFQ28389137-7B63C431-F868-4753-BE86-84D4424166DBQ28485223-601EDE14-39A2-4F78-88A7-77EDF62C0CFBQ28546168-FF863CD7-6EBD-49C2-A9E4-CD3FF7052D4FQ33572376-32DE0BB8-29AA-46D2-964B-FD0C869C1095Q34266877-81EAD81B-F6E3-46F2-8B14-DC9419260574Q34643392-DF9D4E1C-2BA3-47BA-90D4-485C595B732CQ35078327-7C76155B-AF81-44C8-B932-65BA6C5ADD62Q35661017-12500A01-76FC-400D-BF18-A9906DE7CAFEQ35798769-90E1B23B-9155-422A-A378-52580CAD04A4Q35862820-1B1705EB-5272-4CFD-8158-7CE9159384DEQ36093231-385A4015-4EAE-4717-B067-8D63B3D49DA9Q36394805-957036E5-38E8-4BAB-9E07-FD0E5923EE62Q36887316-E8E24909-127E-4588-A456-6DD9073C5E2CQ36890231-E3AEE4DA-D2EF-4081-875E-D00171BCFBC9Q37661249-FDE68093-1CA9-4FFF-BEAF-D57C65BB6420Q37974487-68831AF0-78AA-4C3D-99AC-06A79D60E371Q38021743-782EF21F-74C0-4A81-8AC4-EBC8FFA6E7EFQ38029187-2B39C6CD-ACCE-4A6D-9033-93D5F59ED40AQ38042766-716891DE-B969-4FFA-9E0D-B812D42DE32FQ38211841-8BF0EFC7-EB71-4F0A-86C1-8CEED431B685Q38218439-ED83261C-DECB-4ADC-BC6A-B24ABF3AB851Q38741396-06F273BF-2B95-43F4-BEA2-5D9114C31D25Q38798705-7A99286A-660C-4374-8BB9-CB6A733DA684Q38845581-B4721B99-CD93-457E-8B87-32F81552E9CBQ38869471-79F656E3-40F1-4429-9587-3D9D06DF47F4Q38984981-745B5234-5647-4CD4-999F-7B2238FF24AFQ39013846-96CCC20A-C491-4CFC-8135-2D84A3BA2CE1Q39183454-5AC449DD-4A25-46E2-AFA5-52901DF1D584Q41244371-23586EB8-3B95-4085-8408-EDC73CB27574Q41459008-A05202B8-7351-4B8F-A3ED-151BD2BFAF9CQ42344508-41D0B08E-F2A6-4E4B-8E93-0DF9352AA388Q43846446-A49956D9-79A7-4279-AF46-BDEE93873244Q46545894-F6324A0D-0D69-4ED3-AEF8-5991AE28D266Q47101645-AD36A29F-9B7F-4A0E-9CB2-FFA54001A49BQ47125997-5ED84FAE-6030-4918-BBC5-175B27A18916
P2860
Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Serum lipid profiles are assoc ...... outcomes in multiple sclerosis
@ast
Serum lipid profiles are assoc ...... outcomes in multiple sclerosis
@en
type
label
Serum lipid profiles are assoc ...... outcomes in multiple sclerosis
@ast
Serum lipid profiles are assoc ...... outcomes in multiple sclerosis
@en
prefLabel
Serum lipid profiles are assoc ...... outcomes in multiple sclerosis
@ast
Serum lipid profiles are assoc ...... outcomes in multiple sclerosis
@en
P2093
P2860
P50
P356
P1476
Serum lipid profiles are assoc ...... outcomes in multiple sclerosis
@en
P2093
Barbara Teter
Bijal Mehta
Ellen Carl
Jaclyn Schneider
Jacqueline Durfee
Marc Weiskopf
Naeem Mahfooz
Sara Hussein
P2860
P2888
P356
10.1186/1742-2094-8-127
P577
2011-10-04T00:00:00Z
P5875
P6179
1053113475